HKPD — Hong Kong Pharma Digital Technology Holdings Income Statement
0.000.00%
Last trade - 00:00- $8.25m
- $10.62m
- $20.31m
Annual income statement for Hong Kong Pharma Digital Technology Holdings, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 20-F |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 12.6 | 16.7 | 20.3 |
| Cost of Revenue | |||
| Gross Profit | 2.74 | 3.56 | 2.42 |
| Selling / General / Administrative Expenses | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 11.5 | 15.1 | 20.2 |
| Operating Profit | 1.04 | 1.61 | 0.132 |
| Total Net Non Operating Interest Income / Expense | |||
| Net Income Before Taxes | 1.02 | 1.53 | 0.036 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 0.998 | 1.33 | -0.027 |
| Net Income Before Extraordinary Items | |||
| Net Income | 0.998 | 1.33 | -0.027 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 0.998 | 1.33 | -0.027 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 0.091 | 0.121 | -0.002 |
| Dividends per Share |